HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoxin Chu Selected Research

A-839977

5/2022Blocking connexin 43 and its promotion of ATP release from renal tubular epithelial cells ameliorates renal fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoxin Chu Research Topics

Disease

1Fibrosis (Cirrhosis)
05/2022
1Inflammation (Inflammations)
05/2022
1Vasculitis (Vasculitides)
01/2021
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2021
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2021
1Proteinuria
01/2021

Drug/Important Bio-Agent (IBA)

1A-839977IBA
05/2022
1Adenosine Triphosphate (ATP)IBA
05/2022
1Connexin 43 (Connexin43)IBA
05/2022
13'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA
05/2022
1Serum AlbuminIBA
01/2021
1SteroidsIBA
01/2021
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021
1Rituximab (Mabthera)FDA Link
01/2021
1CreatinineIBA
01/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021

Therapy/Procedure

1Plasma Exchange
01/2021